CN117242362A - 使用动态对比度增强的磁共振断层扫描表征肝脏病变 - Google Patents

使用动态对比度增强的磁共振断层扫描表征肝脏病变 Download PDF

Info

Publication number
CN117242362A
CN117242362A CN202280032200.8A CN202280032200A CN117242362A CN 117242362 A CN117242362 A CN 117242362A CN 202280032200 A CN202280032200 A CN 202280032200A CN 117242362 A CN117242362 A CN 117242362A
Authority
CN
China
Prior art keywords
liver
reference tissue
contrast
regions
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280032200.8A
Other languages
English (en)
Chinese (zh)
Inventor
G·舒茨
G·克诺博罗齐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN117242362A publication Critical patent/CN117242362A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
    • A61B5/4222—Evaluating particular parts, e.g. particular organs
    • A61B5/4244—Evaluating particular parts, e.g. particular organs liver
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5602—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution by filtering or weighting based on different relaxation times within the sample, e.g. T1 weighting using an inversion pulse
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5608—Data processing and visualization specially adapted for MR, e.g. for feature analysis and pattern recognition on the basis of measured MR data, segmentation of measured MR data, edge contour detection on the basis of measured MR data, for enhancing measured MR data in terms of signal-to-noise ratio by means of noise filtering or apodization, for enhancing measured MR data in terms of resolution by means for deblurring, windowing, zero filling, or generation of gray-scaled images, colour-coded images or images displaying vectors instead of pixels
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G06T7/0014—Biomedical image inspection using an image reference approach
    • G06T7/0016—Biomedical image inspection using an image reference approach involving temporal comparison
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/30—Determination of transform parameters for the alignment of images, i.e. image registration
    • G06T7/33—Determination of transform parameters for the alignment of images, i.e. image registration using feature-based methods
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/10—Image acquisition modality
    • G06T2207/10072—Tomographic images
    • G06T2207/10088—Magnetic resonance imaging [MRI]
    • G06T2207/10096—Dynamic contrast-enhanced magnetic resonance imaging [DCE-MRI]
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30056—Liver; Hepatic
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30096—Tumor; Lesion

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Signal Processing (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Artificial Intelligence (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Quality & Reliability (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN202280032200.8A 2021-05-07 2022-04-28 使用动态对比度增强的磁共振断层扫描表征肝脏病变 Pending CN117242362A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21172677.3 2021-05-07
EP21172677 2021-05-07
PCT/EP2022/061289 WO2022233689A1 (de) 2021-05-07 2022-04-28 Charakterisierung von läsionen in der leber mittels dynamischer kontrastverstärkter magnetresonanztomographie

Publications (1)

Publication Number Publication Date
CN117242362A true CN117242362A (zh) 2023-12-15

Family

ID=75870425

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280032200.8A Pending CN117242362A (zh) 2021-05-07 2022-04-28 使用动态对比度增强的磁共振断层扫描表征肝脏病变

Country Status (6)

Country Link
US (1) US20240225448A1 (https=)
EP (1) EP4334733B1 (https=)
JP (1) JP2024517820A (https=)
CN (1) CN117242362A (https=)
CA (1) CA3219070A1 (https=)
WO (1) WO2022233689A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118902432A (zh) * 2024-07-19 2024-11-08 暨南大学附属第一医院（广州华侨医院） 磁共振肝脏半智能化一站式检查方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7803779B2 (ja) * 2022-04-27 2026-01-21 富士フイルム株式会社 磁気共鳴イメージング装置、及び、その制御方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060064396A1 (en) * 2004-04-14 2006-03-23 Guo-Qing Wei Liver disease diagnosis system, method and graphical user interface
US20090097726A1 (en) * 2007-10-12 2009-04-16 General Electric Company Systems, methods and apparatus automatic segmentation of liver in multiphase contrast-enhanced medical images
US20100128946A1 (en) * 2008-11-22 2010-05-27 General Electric Company Systems, apparatus and processes for automated medical image segmentation using a statistical model
US20120070055A1 (en) * 2010-09-22 2012-03-22 Siemens Aktiengesellschaft Method and System for Liver Lesion Detection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039931A (en) 1989-06-30 2000-03-21 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
CN101421745B (zh) 2004-04-15 2016-05-11 美国医软科技公司 空间-时间肿瘤检测，分割和诊断信息提取系统及方法
US9251585B2 (en) 2007-07-12 2016-02-02 Siemens Aktiengesellschaft Coregistration and analysis of multi-modal images obtained in different geometries
EP3101012A1 (en) * 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
EP3629898A4 (en) 2017-05-30 2021-01-20 Arterys Inc. AUTOMATED LESION DETECTION, SEGMENTATION AND LENGTH IDENTIFICATION
CN110709943B (zh) 2017-06-16 2023-11-28 珀金埃尔默细胞科技德国公司 使用沿骨骼的人造界标进行三维图像的自动失真校正和/或共同配准的系统和方法
US11633146B2 (en) 2019-01-04 2023-04-25 Regents Of The University Of Minnesota Automated co-registration of prostate MRI data
EP4597424A3 (en) 2019-01-07 2025-10-29 Exini Diagnostics AB Systems and methods for platform agnostic whole body image segmentation
US20230120273A1 (en) * 2019-10-11 2023-04-20 Bayer Aktiengesellschaft Acceleration of mri examinations
US12254623B2 (en) * 2021-04-01 2025-03-18 GE Precision Healthcare LLC Artificial intelligence assisted diagnosis and classification of liver cancer from image data

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060064396A1 (en) * 2004-04-14 2006-03-23 Guo-Qing Wei Liver disease diagnosis system, method and graphical user interface
US20090097726A1 (en) * 2007-10-12 2009-04-16 General Electric Company Systems, methods and apparatus automatic segmentation of liver in multiphase contrast-enhanced medical images
US20100128946A1 (en) * 2008-11-22 2010-05-27 General Electric Company Systems, apparatus and processes for automated medical image segmentation using a statistical model
US20120070055A1 (en) * 2010-09-22 2012-03-22 Siemens Aktiengesellschaft Method and System for Liver Lesion Detection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHRISTOPH J ZECH ET AL.: "Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging", EUROPEAN RADIOLOGY, 5 August 2019 (2019-08-05), pages 370 - 382 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118902432A (zh) * 2024-07-19 2024-11-08 暨南大学附属第一医院（广州华侨医院） 磁共振肝脏半智能化一站式检查方法

Also Published As

Publication number Publication date
CA3219070A1 (en) 2022-11-10
EP4334733A1 (de) 2024-03-13
US20240225448A1 (en) 2024-07-11
JP2024517820A (ja) 2024-04-23
EP4334733B1 (de) 2026-01-21
WO2022233689A1 (de) 2022-11-10

Similar Documents

Publication Publication Date Title
Haimerl et al. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI
Ingrisch et al. Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer
EP2117428B1 (en) Identification and analysis of lesions in medical imaging
Petrillo et al. Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC
Li et al. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling
Eyal et al. Model‐based and model‐free parametric analysis of breast dynamic‐contrast‐enhanced MRI
CA2731642A1 (en) A computer-based method and system for imaging-based dynamic function evaluation of an organ
Cebulla et al. Multiscale and multi-modality visualization of angiogenesis in a human breast cancer model
Re et al. Enhancing pancreatic adenocarcinoma delineation in diffusion derived intravoxel incoherent motion f‐maps through automatic vessel and duct segmentation
Riches et al. Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters
Wessling et al. Novel deep-learning-based diffusion weighted imaging sequence in 1.5 T breast MRI
JP2022552484A (ja) Ｍｒｉ検査の高速化
Wang et al. Dynamic contrast-enhanced MR imaging in renal cell carcinoma: reproducibility of histogram analysis on pharmacokinetic parameters
US20240225448A1 (en) Characterising lesions in the liver using dynamic contrast-enhanced magnetic resonance tomography
Scalco et al. The quantification of IntraVoxel incoherent motion–MRI maps cannot preserve texture information: An evaluation based on simulated and in-vivo images
van der Reijd et al. Multi-sequence MRI radiomics of colorectal liver metastases: which features are reproducible across readers?
Wu et al. Cortical bone vessel identification and quantification on contrast-enhanced MR images
Niendorf et al. MRI of kidney size matters
US8848998B1 (en) Automated method for contrast media arrival detection for dynamic contrast enhanced MRI
Hales et al. A two-stage model for in vivo assessment of brain tumor perfusion and abnormal vascular structure using arterial spin labeling
US8275181B2 (en) Method for tracking of contrast enhancement pattern for pharmacokinetic and parametric analysis in fast-enhancing tissues using high-resolution MRI
Piantadosi et al. Data-driven selection of motion correction techniques in breast DCE-MRI
Ikoma et al. Reference region extraction by clustering for the pharmacokinetic analysis of dynamic contrast-enhanced MRI in prostate cancer
Fischer et al. Feasibility of semiquantitative liver perfusion assessment by ferucarbotran bolus injection in double‐contrast hepatic MRI
US20170178338A1 (en) Identification and analysis of lesions in medical imaging

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination